1. Home
  2. MSD vs STXS Comparison

MSD vs STXS Comparison

Compare MSD & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morgan Stanley Emerging Markets Debt Fund Inc.

MSD

Morgan Stanley Emerging Markets Debt Fund Inc.

HOLD

Current Price

$6.91

Market Cap

146.9M

Sector

Finance

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.33

Market Cap

139.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSD
STXS
Founded
1993
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.9M
139.3M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
MSD
STXS
Price
$6.91
$1.33
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.00
AVG Volume (30 Days)
56.4K
481.1K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
11.26%
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
N/A
$28.22
Revenue Next Year
N/A
$30.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.91
$1.24
52 Week High
$7.94
$3.59

Technical Indicators

Market Signals
Indicator
MSD
STXS
Relative Strength Index (RSI) 37.46 53.65
Support Level $6.91 $1.28
Resistance Level $7.44 $1.51
Average True Range (ATR) 0.07 0.06
MACD -0.01 0.01
Stochastic Oscillator 16.40 87.97

Price Performance

Historical Comparison
MSD
STXS

About MSD Morgan Stanley Emerging Markets Debt Fund Inc.

Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: